Doctor Stefan Stojkovic

Doctor Stefan Stojkovic

Medical University of Vienna, Vienna (Austria)

Member of:

Dr. Stefan Stojkovic, PhD is a cardiology resident at the Department of Cardiology, Medical University of Vienna, Austria. Main areas of scientific interest are mechanisms of atherosclerotic plaque destabilization and thrombus formation. Dr. Stojkovic graduated at the Medical University of Vienna, Austria, in 2012. After his graduation he enrolled in the PhD program “Vascular Biology”. For his PhD-thesis, under the supervision of Prof. Dr. Johann Wojta, Dr. Stojkovic has received a grant from the Funds of the Austrian National Bank, and completed his PhD with distinction in 2016. For his research in this field, Dr. Stojkovic has received several grants and awards at national and international conferences. With the Exchange grant of the ESC Working group on Thrombosis, Dr. Stojkovic was able to spend a term abroad at the University of Uppsala, Sweden, under under the supervision of Prof. Dr. Agneta Siegbahn.

Presentations

Liver-specific microRNA-122 as a prognostic biomarker in patients with chronic heart failure

Event: Heart Failure 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Access

Liver-specific microRNA-122 as a prognostic biomarker in patients with chronic heart failure

Event: Frontiers in CardioVascular Biology 2018

Topic: Biomarkers

Session: Basic Science - Cardiac Diseases

Access

Circulating micro RNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation

Event: Frontiers in CardioVascular Biology 2018

Topic: Biomarkers

Session: Basic Science - Vascular Diseases

Access

Interleukin-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets

Event: ESC Congress 2017

Topic: Vascular biology, other

Session: Cardiovascular cell biology

Access

Can circulating microRNAs distinguish type 1 and type 2 myocardial infarction?

Event: Frontiers in CardioVascular Biology 2016

Topic: Biomarkers

Session: Biomarkers

Access

Doctor Stefan Stojkovic

Biography

Contributor content

Liver-specific microRNA-122 as a prognostic biomarker in patients with chronic heart failure

Liver-specific microRNA-122 as a prognostic biomarker in patients with chronic heart failure

Circulating micro RNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation

Interleukin-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets

Can circulating microRNAs distinguish type 1 and type 2 myocardial infarction?

ESC 365 is supported by